Physician profile
Sireesha Datla
NPI 1275819526
$7,684.93
in general payments reported to CMS, 2019-2025
66 companies · $3,960 in 2025
The $3,960 reported for 2025 was more than what a typical Medical Oncology provider received nationally (typical 2025 total: $1,158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $238 · 2020: $42.95 · 2021: $11.92 · 2022: $23.36 · 2023: $439 · 2024: $2,969 · 2025: $3,960.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,269 · Long Term Medical Supply Or Device Loan: $99.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,268.88 |
| Long Term Medical Supply Or Device Loan | $99.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $639.34 | 2019-2025 | |
| Daiichi Sankyo INC. | $573.45 | 2023-2025 | Enhertu, Datroway |
| Janssen Biotech, INC. | $539.24 | 2019-2025 | Talvey, Carvykti, Darzalex |
| Astrazeneca Pharmaceuticals LP | $413.88 | 2019-2025 | Enhertu, Calquence, Imfinzi |
| E.R. Squibb & Sons, L.L.C. | $402.79 | 2024-2025 | Opdivo, Krazati, Opdualag |
| Gilead Sciences, INC. | $379.10 | 2021-2025 | Trodelvy |
| Takeda Pharmaceuticals U.S.A., INC. | $357.70 | 2024-2025 | Fruzaqla, Ninlaro, Alunbrig |
| Merck Sharp & Dohme LLC | $309.91 | 2019-2025 | Keytruda, Lynparza, Keytruda Qlex |
| Glaxosmithkline, LLC. | $300.95 | 2023-2025 | Ojjaara, Zejula, Jemperli |
| Pfizer INC. | $293.99 | 2019-2025 | |
| Incyte Corporation | $226.94 | 2023-2025 | Jakafi, Zynyz, Monjuvi |
| Lilly USA, LLC | $221.28 | 2023-2025 | Verzenio, Jaypirca, Retevmo |
| Genentech USA, INC. | $200.98 | 2019-2025 | Tecentriq, Venclexta, Phesgo |
| Dendreon Pharmaceuticals LLC | $179.67 | 2024-2025 | Provenge |
| Bayer Healthcare Pharmaceuticals INC. | $142.59 | 2023-2025 |
Show all 66 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Array Biopharma INC | $130.59 | 2024-2025 | Braftovi, Mektovi, Lorbrena |
| Boehringer Ingelheim Pharmaceuticals, INC. | $125.49 | 2024-2025 | Gilotrif |
| Legend Biotech USA INC. | $105.30 | 2025 | Carvykti |
| Stemline Therapeutics INC. | $100.35 | 2023-2025 | Orserdu |
| Celgene Corporation | $93.80 | 2022-2025 | Reblozyl |
| Emd Serono, INC. | $93.62 | 2019-2025 | |
| Taiho Oncology, INC. | $84.29 | 2024-2025 | |
| Kite Pharma, INC. | $83.58 | 2023-2025 | Yescarta |
| Sobi, INC | $82.71 | 2023-2025 | |
| Abbvie INC. | $82.01 | 2024-2025 | |
| Alexion Pharmaceuticals, INC. | $74.36 | 2024-2025 | Ultomiris |
| Pharmaessentia USA Corporation | $74.23 | 2025 | Besremi |
| Genzyme Corporation | $73.10 | 2020-2025 | |
| Ipsen Biopharmaceuticals, INC | $72.64 | 2024-2025 | Onivyde, Somatuline Depot |
| Blueprint Medicines Corporation | $68.08 | 2024-2025 | Ayvakit |
| Regeneron Healthcare Solutions, INC. | $67.54 | 2025 | Libtayo |
| Rigel Pharmaceuticals, INC. | $62.58 | 2024-2025 | Rezlidhia, Tavalisse, Gavreto |
| Exelixis INC. | $59.79 | 2024-2025 | Cabometyx |
| Tersera Therapeutics LLC | $58.88 | 2025 | Zoladex |
| Immunocore Limited | $56.07 | 2025 | Kimmtrak |
| Fennec Pharmaceuticals, INC. | $49.95 | 2024-2025 | Pedmark, Fyarro |
| Csl Behring | $47.59 | 2023-2025 | Idelvion, Afstyla |
| Janssen Scientific Affairs, LLC | $44.97 | 2025 | Talvey, Tecvayli, Darzalex |
| Janssen Pharmaceuticals, INC | $44.27 | 2024 | Xarelto |
| Adc Therapeutics America, INC. | $41.14 | 2023-2025 | |
| Pharmacosmos Therapeutics INC. | $39.82 | 2024 | Monoferric, Cosela |
| Karyopharm Therapeutics INC. | $39.28 | 2024-2025 | Xpovio |
| Amgen INC. | $31.07 | 2019-2023 | Vectibix, Xgeva, Nplate |
| Puma Biotechnology, INC. | $31.05 | 2024-2025 | |
| Astellas Pharma US INC | $30.80 | 2025 | Xospata, Vyloy |
| Genmab U.S., INC. | $29.27 | 2024 | Epkinly |
| Seagen INC. | $28.45 | 2019 | |
| Springworks Therapeutics, INC. | $27.87 | 2025 | Ogsiveo |
| Medtronic, INC. | $27.85 | 2025 | Kyphon Express II Kyphopak Tray |
| Servier Pharmaceuticals LLC | $24.33 | 2024 | |
| Mirati Therapeutics, INC. | $23.31 | 2024 | Krazati |
| Foundation Medicine, INC. | $23.01 | 2023 | |
| Genentech, INC. | $22.96 | 2025 | Itovebi |
| Jazz Pharmaceuticals INC. | $22.45 | 2024 | |
| Aveo Pharmaceuticals, INC. | $21.95 | 2024 | |
| Syndax Pharmaceuticals, INC. | $21.77 | 2025 | |
| Eisai INC. | $20.93 | 2025 | |
| G1 Therapeutics, INC. | $20.52 | 2023 | Cosela |
| Novo Nordisk INC | $20.19 | 2024 | Novoeight, Novoseven, Rebinyn |
| Geron Corporation | $20.02 | 2024 | Rytelo |
| Alnylam Pharmaceuticals INC. | $17.78 | 2024 | Givlaari |
| Sumitomo Pharma America, INC. | $17.59 | 2024 | Orgovyx |
| Sun Pharmaceutical Industries INC. | $16.86 | 2025 | |
| Pharmacyclics LLC, An Abbvie Company | $16.07 | 2019 | |
| Shield Therapeutics INC | $15.56 | 2024 | |
| Kyowa Kirin, INC. | $15.43 | 2024 | Poteligeo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sireesha Datla listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.